ICNMD 2018 | 15th International Congress On Neuromuscular Disease






The aim of the 15th International Congress On Neuromuscular Disease is to present a wide spectrum of neuromuscular diseases from the perspectives of advances in research, diagnosis and treatment.

Dr Virginia Arechavala and Patricia Soblechero attended the Congress and presented our work on CRISPR/Cas gene editing for in Duchenne muscular dystrophy cultures to test new treatments for the disease and  Myoblots for the evaluation of new treatments in neuromuscular disorders.

Bookmark the permalink.

Comments are closed.